3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
about
Understanding the role of the kynurenine pathway in human breast cancer immunobiologyTrial watch: IDO inhibitors in cancer therapyRequirement of 3-phosphoinositide-dependent protein kinase-1 for BDNF-mediated neuronal survivalIndoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammationSystemic treatment with CpG-B after sublethal rickettsial infection induces mouse death through indoleamine 2,3-dioxygenase (IDO).IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitisAirway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure.Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV diseaseThe kinase PDK1 is essential for B-cell receptor mediated survival signaling.Frontier of epilepsy research - mTOR signaling pathway.Cyclic AMP concentrations in dendritic cells induce and regulate Th2 immunity and allergic asthma.Classification of current anticancer immunotherapiesAmino acid catabolism: a pivotal regulator of innate and adaptive immunity.On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio.Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases.Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilegeInhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infectionTryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesisIDO: a double-edged sword for T(H)1/T(H)2 regulation.T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases.Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production.Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signalingRole of IDO in organ transplantation: promises and difficulties.Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases.Crosstalk between Tryptophan Metabolism and Cardiovascular Disease, Mechanisms, and Therapeutic ImplicationsKynurenine metabolism in health and disease.Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.Persistent infectious diseases say - IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy.O death where is thy sting? Immunologic tolerance to apoptotic self.The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment.IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor DiseaseTargeting TDO in cancer immunotherapy.Respiratory syncytial virus induces indoleamine 2,3-dioxygenase activity: a potential novel role in the development of allergic disease.Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.Expression and regulation of immune-modulatory enzyme indoleamine 2,3-dioxygenase (IDO) by human airway epithelial cells and its effect on T cell activation3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival.
P2860
Q26773472-C2ECC88A-E7D8-4E82-A423-9A28850C386EQ27006866-36317850-C32F-4443-BA42-39006D652ECDQ28565877-09CE9187-6AA2-49D3-9D7C-4BBE788DBF38Q28591402-6A6274DA-6E48-4498-B41B-47371230CE18Q34217664-125C568E-C5A5-4931-998F-6E3B38DE5BA2Q34389464-1CF5C7CE-283E-400A-9F57-241A78F5A8D8Q34526556-FA56EDF4-1841-4E4E-BBFA-6BED80D6C4E9Q34555620-37F88460-F82C-4CC6-AFC3-0F4E8E6EF0B4Q34580922-535B04FA-4E3E-4012-82F7-E71BFB6C8BADQ35014198-FE36F54A-5F3F-49B6-B9CF-00F3F7A46385Q35062625-74CB8329-A368-45CC-B072-B9C8B378A252Q35149637-C415FCFD-D403-463E-B66F-F2A09E1DA5C6Q35261125-50EF52E5-BB29-41C7-B949-99B7ADB0DDB6Q35366914-6F644020-DFC9-4AB9-A818-17129A48F1ECQ35952614-B9345084-15BD-4D80-B134-A3D58CD833ACQ36899012-B26FCF3D-845C-485B-891D-F191B7C3A334Q37006795-21A1ADF4-06F1-48BC-8F9E-88BD1DD3BA25Q37013795-D75F7AC2-1C42-4DCB-A08F-257058224C97Q37079141-23CF25E9-578D-4E08-B847-E96607FBB63FQ37081582-D9BDCADE-2842-4B61-A00C-012D444D429BQ37281950-58CE8E9E-7218-4987-939D-8F036BF49C09Q37334065-5D57CC0E-2CEF-42DB-8ED9-DD361E3B8E99Q37352554-42B5BAE4-D555-43B2-BE1D-01C9BDCC41EDQ37522460-3B8CC702-0A63-4ED0-8FE7-8986964C8B34Q37549093-242236CD-BC70-4ED4-8519-15E320901574Q37550184-F0297F54-D321-4DB2-BD62-F454F9FD4467Q37610449-5F08B319-5646-4B87-9EB1-04DE41CAEB7CQ37623378-822D6261-D99A-4C21-9DFD-D45E2DE3BD07Q37717023-EE5CD5A9-162D-4B8E-8EF4-82256663A027Q37802769-06E101A7-476F-4D1B-8BF4-C428E059C34FQ38047057-745F253C-7800-40CD-80BF-3A4800F9C0E1Q38061723-C9CA3567-9CAD-4DF3-9A55-7F6F3B4EF9DFQ38078769-E9CA0B90-6A4D-4588-AF11-1549A50951C8Q38356502-B2A102D5-6D56-45C5-A10D-940E348F754FQ38728766-5912C52D-6B18-40A1-89ED-109D562C10CFQ38737804-1E211BDE-6994-400F-AE9F-DDE41471D47BQ38915839-C459C0C5-A755-4646-83AC-A24C89782D1CQ39185463-5D6BD508-68DD-41F9-98B0-9DA4F633F1B5Q39404674-3E11012E-01CC-4B9E-B6E8-5A02D43B47F0Q39611354-A4A46520-D3ED-4A45-9F67-E0BF54A2E356
P2860
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
3-Hydroxyanthranilic acid inhi ...... by inducing T cell apoptosis.
@ast
3-Hydroxyanthranilic acid inhi ...... by inducing T cell apoptosis.
@en
type
label
3-Hydroxyanthranilic acid inhi ...... by inducing T cell apoptosis.
@ast
3-Hydroxyanthranilic acid inhi ...... by inducing T cell apoptosis.
@en
prefLabel
3-Hydroxyanthranilic acid inhi ...... by inducing T cell apoptosis.
@ast
3-Hydroxyanthranilic acid inhi ...... by inducing T cell apoptosis.
@en
P2093
P2860
P50
P356
P1476
3-Hydroxyanthranilic acid inhi ...... by inducing T cell apoptosis.
@en
P2093
Angela Jang
David H Broide
Gregory I Elliott
Jongdae Lee
Lucinda Beck
Tomoko Hayashi
P2860
P304
18619-18624
P356
10.1073/PNAS.0709261104
P407
P577
2007-11-14T00:00:00Z